Literature DB >> 27037085

Varicella Zoster Virus and Giant Cell Arteritis.

Anne A Gershon1, Michael Gershon2.   

Abstract

Keywords:  antiviral therapy; arteritis; giant cell; reactivation; varicella zoster

Mesh：

Year:  2016        PMID： 27037085      PMCID： PMC4878729          DOI： 10.1093/infdis/jiw110

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  31 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

Review 2.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy.

Authors:  Esteban Cheng-Ching; Stephen Jones; Ferdinand K Hui; Shumei Man; Don Gilden; Adarsh Bhimraj; Ken Uchino
Journal:  J Neurol Sci       Date:  2015-02-16       Impact factor: 3.181

4.  Varicella Zoster Virus in Temporal Arteries of Patients With Giant Cell Arteritis.

Authors:  Don Gilden; Maria Nagel
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

5.  Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)?

Authors:  Jacques Gaillat; Vincent Gajdos; Odile Launay; Denis Malvy; Bruno Demoures; Lucie Lewden; Sybil Pinchinat; Tarik Derrough; Claudine Sana; Evelyne Caulin; Benoît Soubeyrand
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

6.  Use of Saliva to Identify Varicella Zoster Virus Infection of the Gut.

Authors:  Anne A Gershon; Jason Chen; Michael D Gershon
Journal:  Clin Infect Dis       Date:  2015-04-16       Impact factor: 9.079

7.  Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Authors:  Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

8.  Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Authors:  M Brisson; N J Gay; W J Edmunds; N J Andrews
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

Review 9.  Varicella zoster virus vasculopathy: clinical features and pathogenesis.

Authors:  Maria A Nagel
Journal:  J Neurovirol       Date:  2013-08-06       Impact factor: 2.643

10.  Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.

Authors:  Elchonon M Berkowitz; Graeme Moyle; Hans-Jürgen Stellbrink; Dirk Schürmann; Stephen Kegg; Matthias Stoll; Mohamed El Idrissi; Lidia Oostvogels; Thomas C Heineman
Journal:  J Infect Dis       Date:  2014-11-03       Impact factor: 5.226
View more
  1 in total

Review 1.  Clinical Features of Varicella-Zoster Virus Infection.

Authors:  Peter G E Kennedy; Anne A Gershon
Journal:  Viruses       Date:  2018-11-02       Impact factor: 5.048
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.